Logo image of WAI

TOP KINGWIN LTD-A (WAI) Stock Fundamental Analysis

USA - NASDAQ:WAI - KYG8923U1114 - Common Stock

3.59 USD
+0.2 (+5.9%)
Last: 9/19/2025, 8:00:02 PM
3.32 USD
-0.27 (-7.52%)
After Hours: 9/19/2025, 8:00:02 PM
Fundamental Rating

2

Taking everything into account, WAI scores 2 out of 10 in our fundamental rating. WAI was compared to 236 industry peers in the Capital Markets industry. While WAI seems to be doing ok healthwise, there are quite some concerns on its profitability. WAI has a expensive valuation and it also scores bad on growth.


Dividend Valuation Growth Profitability Health

Quickly go to:

1

1. Profitability

1.1 Basic Checks

WAI had negative earnings in the past year.
WAI had a negative operating cash flow in the past year.
The reported net income has been mixed in the past 5 years: WAI reported negative net income in multiple years.
The reported operating cash flow has been mixed in the past 5 years: WAI reported negative operating cash flow in multiple years.
WAI Yearly Net Income VS EBIT VS OCF VS FCFWAI Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2020 2021 2022 2023 2024 0 -10M -20M -30M

1.2 Ratios

Looking at the Return On Assets, with a value of -6.13%, WAI is doing worse than 82.20% of the companies in the same industry.
The Return On Equity of WAI (-7.14%) is worse than 78.39% of its industry peers.
Industry RankSector Rank
ROA -6.13%
ROE -7.14%
ROIC N/A
ROA(3y)-20.31%
ROA(5y)-0.54%
ROE(3y)-33.69%
ROE(5y)11.43%
ROIC(3y)N/A
ROIC(5y)N/A
WAI Yearly ROA, ROE, ROICWAI Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2020 2021 2022 2023 2024 0 20 -20 40 -40 60 80

1.3 Margins

The Gross Margin of WAI (65.89%) is better than 74.15% of its industry peers.
WAI's Gross Margin has declined in the last couple of years.
WAI does not have Profit Margin and Operating Margin available, so we won't be analyzing them here.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 65.89%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-23.26%
GM growth 5YN/A
WAI Yearly Profit, Operating, Gross MarginsWAI Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2020 2021 2022 2023 2024 0 -100 -200

More info and screens

5

2. Health

2.1 Basic Checks

The number of shares outstanding for WAI has been increased compared to 1 year ago.
Compared to 1 year ago, WAI has a worse debt to assets ratio.
WAI Yearly Shares OutstandingWAI Yearly Shares OutstandingYearly Shares Outstanding 2020 2021 2022 2023 2024 50M 100M 150M
WAI Yearly Total Debt VS Total AssetsWAI Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2020 2021 2022 2023 2024 10M 20M 30M 40M

2.2 Solvency

WAI has an Altman-Z score of 1.39. This is a bad value and indicates that WAI is not financially healthy and even has some risk of bankruptcy.
WAI has a Altman-Z score of 1.39. This is in the better half of the industry: WAI outperforms 62.71% of its industry peers.
WAI has a Debt/Equity ratio of 0.06. This is a healthy value indicating a solid balance between debt and equity.
Looking at the Debt to Equity ratio, with a value of 0.06, WAI belongs to the top of the industry, outperforming 83.47% of the companies in the same industry.
Industry RankSector Rank
Debt/Equity 0.06
Debt/FCF N/A
Altman-Z 1.39
ROIC/WACCN/A
WACCN/A
WAI Yearly LT Debt VS Equity VS FCFWAI Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2020 2021 2022 2023 2024 0 20M -20M

2.3 Liquidity

A Current Ratio of 7.29 indicates that WAI has no problem at all paying its short term obligations.
WAI has a better Current ratio (7.29) than 90.68% of its industry peers.
WAI has a Quick Ratio of 7.29. This indicates that WAI is financially healthy and has no problem in meeting its short term obligations.
WAI has a Quick ratio of 7.29. This is amongst the best in the industry. WAI outperforms 90.68% of its industry peers.
Industry RankSector Rank
Current Ratio 7.29
Quick Ratio 7.29
WAI Yearly Current Assets VS Current LiabilitesWAI Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2020 2021 2022 2023 2024 10M 20M 30M 40M

More info and screens

0

3. Growth

3.1 Past

WAI shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 39.40%, which is quite impressive.
The Revenue for WAI has decreased by -31.16% in the past year. This is quite bad
Measured over the past years, WAI shows a very negative growth in Revenue. The Revenue has been decreasing by -15.85% on average per year.
EPS 1Y (TTM)39.4%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%44.61%
Revenue 1Y (TTM)-31.16%
Revenue growth 3Y-15.85%
Revenue growth 5YN/A
Sales Q2Q%722.88%

3.2 Future

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
WAI Yearly Revenue VS EstimatesWAI Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2020 2021 2022 2023 2024 2M 4M 6M

More info and screens

0

4. Valuation

4.1 Price/Earnings Ratio

WAI reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.
Industry RankSector Rank
PE N/A
Fwd PE N/A
WAI Price Earnings VS Forward Price EarningsWAI Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 0 0 0 0 0 0 0 0 0 0

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
WAI Per share dataWAI EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 10 -10

4.3 Compensation for Growth

PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2YN/A
EPS Next 3YN/A

More info and screens

0

5. Dividend

5.1 Amount

No dividends for WAI!.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

TOP KINGWIN LTD-A

NASDAQ:WAI (9/19/2025, 8:00:02 PM)

After market: 3.32 -0.27 (-7.52%)

3.59

+0.2 (+5.9%)

Chartmill FA Rating
GICS SectorFinancials
GICS IndustryGroupFinancial Services
GICS IndustryCapital Markets
Earnings (Last)N/A N/A
Earnings (Next)N/A N/A
Inst Owners0.11%
Inst Owner ChangeN/A
Ins Owners0.03%
Ins Owner ChangeN/A
Market Cap7.43M
AnalystsN/A
Price TargetN/A
Short Float %N/A
Short Ratio0.22
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)N/A
PT rev (3m)N/A
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)N/A
EPS NY rev (3m)N/A
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)N/A
Revenue NY rev (3m)N/A
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S 1.36
P/FCF N/A
P/OCF N/A
P/B 0.21
P/tB 0.21
EV/EBITDA N/A
EPS(TTM)-2.16
EYN/A
EPS(NY)N/A
Fwd EYN/A
FCF(TTM)-19.05
FCFYN/A
OCF(TTM)-19.02
OCFYN/A
SpS2.63
BVpS17.25
TBVpS17.22
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -6.13%
ROE -7.14%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM 65.89%
FCFM N/A
ROA(3y)-20.31%
ROA(5y)-0.54%
ROE(3y)-33.69%
ROE(5y)11.43%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-23.26%
GM growth 5YN/A
F-Score4
Asset Turnover0.13
Health
Industry RankSector Rank
Debt/Equity 0.06
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr 60.4%
Cap/Sales 0.99%
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 7.29
Quick Ratio 7.29
Altman-Z 1.39
F-Score4
WACCN/A
ROIC/WACCN/A
Cap/Depr(3y)82.9%
Cap/Depr(5y)408.17%
Cap/Sales(3y)1.53%
Cap/Sales(5y)3.34%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)39.4%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%44.61%
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)-31.16%
Revenue growth 3Y-15.85%
Revenue growth 5YN/A
Sales Q2Q%722.88%
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y-186.66%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y-2169.52%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y-2291.96%
OCF growth 3YN/A
OCF growth 5YN/A